US2009062532A1PendingUtilityA1
Chemical Intermediate
Est. expiryOct 14, 2022(expired)· nominal 20-yr term from priority
Inventors:David Cladingboel
C07D 498/08
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An acid addition salt of a compound of Formula I, wherein R 2 represents C 1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from —OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted.
Claims
exact text as granted — not AI-modified1 . An acid addition salt of a compound of Formula I
wherein R 2 represents C 1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from —OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted.
2 . A salt according to claim 1 in which the acid component of the acid addition salt is represented by formula A
wherein R 16 represents unsubstituted C 1-4 alkyl, C 1-4 perfluoroalkyl or phenyl, which latter group is optionally substituted by one or more substituents selected from C 1-6 alkyl, halo, nitro and C 1-6 alkoxy, and R 2 is as defined above.
3 . A salt according to claim 2 wherein the salt is a toluenesulfonate, benzenesulfonate, nosylate, brosylate, besylate or mesitylate salt.
4 . A salt according to any previous claim in which the salt is in solid form.
5 . A salt according to any previous claim which is [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbamic acid tert-butyl ester 2,4,6-trimethylbenzenesulfonic acid.
6 . A process for the preparation of a compound of Formula II
wherein R 1 represents a structural fragment of formula Ia
in which A represents CH 2 and R 3 represents —OH or —N(H)R 7 ;
R 4 represents H, C 1-6 alkyl or, together with R 3 , represents ═O;
R 5 represents phenyl or pyridyl, both of which groups are optionally substituted by one or more substituents selected from —OH, cyano, halo, nitro, C 1-6 alkyl (optionally terminated by —N(H)C(O)OR 13a ), C 1-6 alkoxy,
—N(R 14a )R 14b , —C(O)R 14c , —C(O)OR 14d , —C(O)N(R 14e )R 14f , —N(R 14g )C(O)R 14h ,
—N(R 14i )C(O)N(R 14j )R 14k , —N(R 14m )S(O) 2 R 13b , —S(O) 2 R 13c and/or
—OS(O) 2 R 13d ;
R 7 represents H, C 1-6 alkyl, -E-aryl, -E-Het 1 , —C(O)R 9a , —C(O)OR 9b ,
—S(O) 2 R 9c , —[C(O)] p N(R 10a )R 10b or —C(NH)NH 2 ;
R 9a to R 9d independently represent, at each occurrence when used herein, C 1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from halo, aryl and Het 2 ), aryl, Het 3 , or R 9a and R 9d independently represent H;
R 10a and R 10b independently represent, at each occurrence when used herein, H or C 1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from halo, aryl and Het 4 ), aryl, Het 5 , or together represent C 3-6 alkylene, optionally interrupted by an O atom;
E represents, at each occurrence when used herein, a direct bond or C 1-4 alkylene;
B represents -Z-, -Z-N(R 12 )—, —N(R 12 )-Z-, -Z-S(O) n — or -Z-O— (in which latter two groups, Z is attached to the carbon atom bearing R 3 and R 4 );
Z represents a direct bond or C 1-4 alkylene;
R 11 and R 12 independently represent H or C 1-6 alkyl;
R 13a to R 13d independently represent C 1-6 alkyl;
R 14a and R 14b independently represent H, C 1-6 alkyl or together represent C 3-6 alkylene, resulting in a four- to seven-membered nitrogen-containing ring;
R 14c to R 14m independently represent H or C 1-6 alkyl; and
n represents 0, 1 or 2;
p represents 1 or 2;
Het 1 to Het 5 independently represent, at each occurrence when used herein, five- to twelve-membered heterocyclic groups containing one or more heteroatoms selected from oxygen, nitrogen and/or sulfur, which heterocyclic groups are optionally substituted by one or more substituents selected from ═O, —OH, cyano, halo, nitro, C 1-6 alkyl, C 1-6 alkoxy, aryl, aryloxy, —N(R 15a )R 15b , —C(O)R 15c , —C(O)OR 15d , —C(O)N(R 15e )R 15f , —N(R 15g )C(O)R 15h and —N(R 15i )S(O) 2 R 15j ;
R 15a R 15i independently represent C 1-6 alkyl aryl or R 15a to R 15i independently represent H;
and R 2 represents C 1-6 alkyl (optionally substituted and/or terminated by one or more substituents selected from —OH, halo, cyano, nitro and aryl) or aryl, wherein each aryl and aryloxy group, unless otherwise specified, is optionally substituted.
wherein a salt of a compound of Formula I
in which R 2 is as previously defined is reacted with a compound of Formula III
wherein Y represents O or N(R 7 ) and R 4 , R 5 , R 7 and B are as hereinbefore defined, at a temperature in the range of 0° C. to 100° C. for example at elevated temperature (e.g. 60° C. to reflux) in the presence of a water and in the presence of a base.
7 . A process according to claim 6 in which the salt has been previously isolated in solid form.
8 . A process according to either claim 6 or claim 7 for the preparation of tert-butyl 2-{7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diaza-bicyclo[3.3.1]-non-3-yl}ethylcarbamate which comprises reacting a salt of [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbamic acid tert-butyl ester with 4-[(2S)-oxiranylmethoxy]benzonitrile at a temperature in the range of 0° C. to 100° C. in the presence of water and in the presence of a base.
9 . A process according to any one of claims 6 , 7 or 8 in which an isolated salt of [2-(9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl)-ethyl]-carbamic acid tert-butyl ester is used.
10 . A process according to either claim 9 wherein the salt is the 2,4,6-trimethylbenzenesulfonic acid salt.Join the waitlist — get patent alerts
Track US2009062532A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.